?LEADERSHIP GROUP The leadership group (LG) will provide strategic and operational direction to the Center. The LG consists of a director, a senior project manager, the disease-specific group leaders, the centralized group leaders, an operations team, and various other Center committees. DAIT staff representing each of the three disease areas, bioinformatics, regulatory, and statistics (as needed) will also be considered part of the larger, external leadership group. The proposed LG steering committee provides consistency and clear communication across multiple studies and functional groups. The LG structure is designed to meet the following primary objectives: ? Centralize and facilitate open lines of communication between Center group leaders and DAIT ? Standardize processes and procedures across the entire program ? Address high-level issues regarding study design, implementation, and analysis ? Keep the Center current with industry and NIH standards ? Provide administrative support to the Center ? Allocate resources across the Center ? Manage the financial aspects of the Center Members of the LG will build on our past success with coordinating DAIT studies to develop effective collaboration and communication channels for the Center. These same channels will be used for decision- making and issue resolution. We have found through our work with large multi-protocol NIH coordinating centers that effective communication requires a combination of approaches, including scheduled and ad hoc meetings and teleconferences, use of a collaboration portal to share documents and status information, and other tools and processes we have developed over time. Ongoing monitoring and tracking of LG functions and progress is essential to maintaining timely, high quality work across the Center. Activities must be monitored at the group level and across the Center. The LG director and senior project manager assume responsibility for monitoring work across the Center. With the goal of providing all stakeholders with the information needed to evaluate progress and identify issues and monitor resources, Rho utilizes a number of standard processes, tools, and activities that can be tailored to the needs of individual projects. As new needs arise, Rho refines these items to continuously improve our tracking and monitoring methods.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Program Project or Center with Complex Structure Cooperative Agreement (UM2)
Project #
1UM2AI117870-01
Application #
8892715
Study Section
Special Emphasis Panel (ZAI1-PA-I (J2))
Project Start
2015-05-07
Project End
2022-04-30
Budget Start
2015-05-07
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$1,598,654
Indirect Cost
$593,211
Name
Rho Federal Systems Division, Inc.
Department
Type
DUNS #
362726007
City
Chapel Hill
State
NC
Country
United States
Zip Code
27517
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Gill, Michelle A; Liu, Andrew H; Calatroni, Agustin et al. (2018) Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol 141:1735-1743.e9
Wildfire, Jeremy; Bailey, Ryan; Krouse, Rebecca Z et al. (2018) The Safety Explorer Suite: Interactive Safety Monitoring for Clinical Trials. Ther Innov Regul Sci 52:696-700
Simpson, Eric L; Villarreal, Miguel; Jepson, Brett et al. (2018) Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol 138:2224-2233
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Gergen, Peter J; Mitchell, Herman E; Calatroni, Agustin et al. (2018) Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population. J Allergy Clin Immunol Pract 6:101-107.e2
du Toit, George; Sayre, Peter H; Roberts, Graham et al. (2018) Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol 141:1343-1353
Calabrese, Sarah K; Underhill, Kristen; Mayer, Kenneth H (2017) HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities. Am J Public Health 107:1572-1576
Bahnson, Henry T; du Toit, George; Lack, Gideon (2017) Statistical Considerations of Food Allergy Prevention Studies. J Allergy Clin Immunol Pract 5:274-282
Keever-Taylor, Carolyn A; Heimfeld, Shelly; Steinmiller, Kaitlyn C et al. (2017) Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases. Biol Blood Marrow Transplant 23:1463-1472

Showing the most recent 10 out of 33 publications